沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

交易中 12-23 13:19:41

6.350

+0.320

+5.31%

最高6.400	最低6.000	成交量103.00万
今开6.170	昨收6.030	日振幅6.63%
总市值42.61亿	流通市值42.61亿	总股本6.71亿
成交额643.71万	换手率0.15%	流通股本6.71亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":6.35,"timestamp":1766467071515,"preClose":6.03,"halted":0,"volume":1030000,"delay":0,"floatShares":671000000,"shares":671000000,"eps":-0.3750700735615553,"marketStatus":"交易中","change":0.32,"latestTime":"12-23 13:19:41","open":6.17,"high":6.4,"low":6,"amount":6437080,"amplitude":0.066335,"askPrice":6.38,"askSize":20000,"bidPrice":6.35,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-0.37652854579609357,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1766477400000},"marketStatusCode":2,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":6.03,"openAndCloseTimeList":[[1766453400000,1766462400000],[1766466000000,1766476800000]],"volumeRatio":1.905654,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2593211485","title":"东方海洋（002086）披露全资子公司取得医疗器械注册证，12月22日股价下跌0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593211485","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593211485?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:53","pubTimestamp":1766397185,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘，东方海洋报收于2.4元，较前一交易日下跌0.41%，最新总市值为47.01亿元。该股当日开盘2.42元，最高2.42元，最低2.4元，成交额达7200.52万元，换手率为1.89%。公司近日发布公告称，其全资子公司艾维可生物科技有限公司自主研发的降钙素原测定试剂盒已取得山东省药品监督管理局颁发的医疗器械注册证，注册证编号为鲁械注准20252400747，有效期至2030年12月10日。该产品适用于体外定量检测人血清、血浆、全血中的降钙素原含量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200022621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002086","BK1574","09996","BK0213","BK0092","BK1222","09997","BK0046","BK1100","BK1583","159883"],"gpt_icon":0},{"id":"2593107719","title":"东方海洋(002086.SZ)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2593107719","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593107719?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:15","pubTimestamp":1766391307,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东方海洋(002086.SZ)发布公告，公司全资子公司艾维可生物科技有限公司自主研发的降钙素原(PCT)测定试剂盒(荧光免疫层析法)于近日取得了山东省药品监督管理局的注册批准，获得医疗器械注册证。上述产品获准上市，进一步丰富了艾维可生物科技有限公司在临床检测领域的产品线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1222","BK0046","BK0213","BK0092","BK1100","BK1583","002086","BK1574","159883","09997"],"gpt_icon":0},{"id":"2593109015","title":"脑机接口医疗器械工作推进会召开；官方成立南极磷虾油事件调查组 | 健讯Daily","url":"https://stock-news.laohu8.com/highlight/detail?id=2593109015","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593109015?lang=zh_cn&edition=full","pubTime":"2025-12-22 07:42","pubTimestamp":1766360520,"startTime":"0","endTime":"0","summary":"国家药监局在北京召开脑机接口医疗器械工作推进会12月19日消息，国家药监局12月18日在北京召开脑机接口医疗器械工作推进会。下一步将根据调查结果依法依规进行严肃查处，坚决保护消费者合法权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222074642a467b9a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222074642a467b9a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1583","BK1574","BK1100","09997","09996","BK1222","BK1191"],"gpt_icon":0},{"id":"2593260651","title":"亚虹医药：APLD-2304申报欧洲医疗器械注册获接收","url":"https://stock-news.laohu8.com/highlight/detail?id=2593260651","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593260651?lang=zh_cn&edition=full","pubTime":"2025-12-21 15:51","pubTimestamp":1766303467,"startTime":"0","endTime":"0","summary":"亚虹医药(688176.SH)公告称，公司产品APLD-2304向欧盟公告机构提交了医疗器械注册申请材料，并获得欧盟公告机构接收，后续尚需通过欧盟公告机构的审评、审批后方可上市销售。APLD-2304 是公司针对膀胱癌诊断及随访监测的使用场景和需求，研发的世界上首款便携式一次性蓝光膀胱软镜。由于产品的研发周期长、审批环节多、研发投入大，容易受到一些不确定性因素的影响，对公司近期业绩不会产生重大影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122100001531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1222","09996","BK0239","BK1100","09997","BK1574","688176","159883","BK1583"],"gpt_icon":0},{"id":"2592019874","title":"戴维医疗（300314）披露全资子公司申报医疗器械注册获得受理，12月19日股价上涨0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592019874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592019874?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:48","pubTimestamp":1766155711,"startTime":"0","endTime":"0","summary":"截至2025年12月19日收盘，戴维医疗报收于12.91元，较前一交易日上涨0.7%，最新总市值为37.18亿元。该股当日开盘12.76元，最高12.96元，最低12.74元，成交额达2686.75万元，换手率为1.45%。公司近日发布公告称，其全资子公司宁波维尔凯迪医疗器械有限公司申报的一次性腔镜用电动直线型切割吻合器及组件已获浙江省药品监督管理局受理，受理号为械受20254041167。目前该事项处于注册申请受理阶段，后续需经技术审评、行政审批和制证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900040042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","159883","BK1100","BK1222","BK0251","BK1574","BK0048","BK0046","09996","09997","300314","BK0042"],"gpt_icon":0},{"id":"2592163072","title":"透景生命(300642.SZ)子公司取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2592163072","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592163072?lang=zh_cn&edition=full","pubTime":"2025-12-19 18:45","pubTimestamp":1766141114,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)公告，公司全资子公司上海透景诊断科技有限公司近日取得上海市药品监督管理局颁发的5项医疗器械注册证，产品包括：抗双链DNA抗体IgG测定试剂盒(流式荧光发光法)、抗补体1q抗体IgG测定试剂盒(流式荧光发光法)、抗M2-3E抗体IgG测定试剂盒(流式荧光发光法)、抗磷脂综合征IgA抗体测定试剂盒(流式荧光发光法)、抗核小体抗体IgG测定试剂盒(流式荧光发光法)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383832.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","09997","159883","BK1100","BK0046","BK1574","BK1222","BK0042","09996","BK0239","300642"],"gpt_icon":0},{"id":"2592157178","title":"四川宜宾召开2025年医疗器械不良事件报告质量评估会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2592157178","media":"中国消费网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592157178?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:59","pubTimestamp":1766134740,"startTime":"0","endTime":"0","summary":"中国消费者报成都讯 12月17日，四川省宜宾市药品不良反应监测中心组织召开2025年医疗器械不良事件报告质量评估会议。宜宾市属医疗机构、各区县医疗器械监测专家以及相关工作人员参会。宜宾市市场监管局供图会议解读了《四川省医疗器械不良事件严重报告质量评估计分标准（试行）》。评分人员依据《计分标准》对随机抽取的260份报告进行交叉评分，并对质量评估结果进行了现场通报和交流讨论。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-12-19/doc-inhcipui7678836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1222","BK1574","BK1100","09997","159883","BK1583","09996"],"gpt_icon":0},{"id":"2592132485","title":"港股异动 | 脑机接口概念股午前拉升 国家药监局在北京召开脑机接口医疗器械工作推进会","url":"https://stock-news.laohu8.com/highlight/detail?id=2592132485","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592132485?lang=zh_cn&edition=full","pubTime":"2025-12-19 11:51","pubTimestamp":1766116260,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，脑机接口概念股午前拉升，截至发稿，南京熊猫涨4.16%，报4.51港元；微创脑科学涨4.24%，报10.83港元；脑动极光-B涨2.58%，报5.96港元。消息面上，国家药监局12月18日在北京召开脑机接口医疗器械工作推进会。国泰海通指出，伴随技术创新突破、政策支持引导、资本投入等多重因素驱动，脑机接口行业有望迎来重要发展机遇，有望在医疗健康、生活消费等下游市场迎来需求释放，市场前景可期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","00553","BK1149","09996","BK1100","BK1189","02172","09997","BK1574","159883","06681","BK1583"],"gpt_icon":0},{"id":"2592236902","title":"戴维医疗（300314）披露全资子公司部分医疗器械产品完成延续注册，12月18日股价上涨2.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592236902","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592236902?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:42","pubTimestamp":1766068946,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘，戴维医疗报收于12.82元，较前一交易日上涨2.15%，最新总市值为36.92亿元。该股当日开盘12.45元，最高12.91元，最低12.45元，成交额达3777.55万元，换手率为2.06%。公司近日发布公告称，其全资子公司宁波维尔凯迪医疗器械有限公司取得浙江省药品监督管理局颁发的《医疗器械注册证》，产品一次性使用腔镜切割吻合器及组件完成延续注册，注册证编号为浙械注准20162021053，有效期至2031年7月19日。延续注册完成后，维尔凯迪可继续生产和销售该产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800039270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK0048","BK0046","BK0251","BK1583","BK1100","BK1574","300314","BK1222","159883","09996","BK0042"],"gpt_icon":0},{"id":"2592743559","title":"南京医药最新公告：拟1.2亿元参设南药医疗器械投资公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2592743559","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592743559?lang=zh_cn&edition=full","pubTime":"2025-12-18 17:52","pubTimestamp":1766051533,"startTime":"0","endTime":"0","summary":"南京医药公告称，公司拟与南京新工新兴产业投资管理有限公司、南京新工医疗健康强链并购股权投资基金合伙企业共同投资设立南京新工南药医疗器械强链并购股权投资有限责任公司，其中公司拟出资1.2亿元，占南药医疗器械投资公司认缴出资总额的59.9%。南药医疗器械投资公司成立后，专项用于投资宁波江丰生物信息技术有限公司。南药医疗器械投资公司将以江丰生物整体估值不超过7.5亿元为前提受让江丰生物约22.5%的股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800027420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK0250","600713","09996","09997","BK1100","BK1222","BK0209","159883","BK1574"],"gpt_icon":0},{"id":"2592923194","title":"无锡时代天使医疗器械科技有限公司旗下产品无托槽扩弓矫治器拿到国家药监局审批的二类证","url":"https://stock-news.laohu8.com/highlight/detail?id=2592923194","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592923194?lang=zh_cn&edition=full","pubTime":"2025-12-17 17:54","pubTimestamp":1765965240,"startTime":"0","endTime":"0","summary":"产品名称：无托槽扩弓矫治器所属单位：无锡时代天使医疗器械科技有限公司产品类型：医用耗材审批机构：江苏省药品监督管理局证件类型：二类注册证编号：苏械注准20252172205获批时间：2025-11-28","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217175425a6ad7c44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217175425a6ad7c44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1100","BK1587","06699","BK1222","BK1574","09996","BK1593","09997"],"gpt_icon":0},{"id":"2591945980","title":"圣湘生物（688289）披露相关产品取得医疗器械注册证，12月16日股价下跌1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591945980","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591945980?lang=zh_cn&edition=full","pubTime":"2025-12-16 22:12","pubTimestamp":1765894370,"startTime":"0","endTime":"0","summary":"截至2025年12月16日收盘，圣湘生物报收于18.51元，较前一交易日下跌1.96%，最新总市值为107.24亿元。公司近日发布公告称，圣湘生物科技股份有限公司的四款产品近日获得国家药品监督管理局颁发的《医疗器械注册证》。上述产品均为境内第三类体外诊断试剂，有效期至2030年12月11日。此次获批丰富了公司呼吸道感染快速检测体系，提升了EB病毒检测能力，并扩展了药物基因组学应用，有助于临床精准用药和疾病管理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600040620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0239","BK1100","159883","09997","09996","BK1222","688289","BK1583"],"gpt_icon":0},{"id":"2591298724","title":"济南高新区首家医疗器械多仓协同经营企业获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2591298724","media":"济南高新区","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591298724?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:21","pubTimestamp":1765887660,"startTime":"0","endTime":"0","summary":"近日，山东九州通医药有限公司获批医疗器械多仓协同经营资质，成为《山东省医疗器械多仓协同经营监督管理办法》正式施行以来，济南高新区首家获此资质企业。下一步，济南高新区将持续聚焦企业发展核心需求，深化审批服务改革创新，在严守安全底线的基础上，进一步推广多仓协同等先进经营模式，助力更多医疗器械企业提升质量管理水平与市场竞争力，为区域医疗器械产业高质量发展注入强劲动能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-16/doc-inhaziex2920348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1574","BK1222","09997","09996","159883","BK1583"],"gpt_icon":0},{"id":"2591798639","title":"圣湘生物(688289.SH)：四款产品取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2591798639","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591798639?lang=zh_cn&edition=full","pubTime":"2025-12-16 19:12","pubTimestamp":1765883539,"startTime":"0","endTime":"0","summary":"智通财经APP讯，圣湘生物(688289.SH)发布公告，公司的四款产品于近日收到由国家药品监督管理局颁发的《医疗器械注册证》，产品名称分别为：大肠埃希菌、鲍曼不动杆菌、嗜麦芽窄食单胞菌核酸检测试剂盒(荧光PCR法);肺炎链球菌、流感嗜血杆菌、卡他莫拉菌核酸检测试剂盒(荧光PCR法);人CYP3A5基因多态性核酸检测试剂盒(PCR-荧光探针法);EB病毒核酸检测试剂盒(荧光PCR法)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382217.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","159883","BK1100","BK1222","BK1574","BK0239","09996","09997","688289"],"gpt_icon":0},{"id":"2591983355","title":"普门科技(688389.SH)取得两个医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2591983355","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591983355?lang=zh_cn&edition=full","pubTime":"2025-12-16 18:11","pubTimestamp":1765879918,"startTime":"0","endTime":"0","summary":"智通财经APP讯，普门科技(688389.SH)发布公告，公司于近期收到了2个广东省药品监督管理局颁发的《中华人民共和国医疗器械注册证(体外诊断试剂)》，产品名称：性激素类质控品、甲状腺功能质控品。本次取得注册证的产品均为复合质控品，以样本测量程序对质控品进行测定，将测定结果进行统计分析或与参考值(参考范围)比较，判断结果是否满足要求，以此确保公司电化学发光检测系统的安全、有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382164.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","09996","BK1100","BK0251","09997","BK1574","688389","159883","BK1583"],"gpt_icon":0},{"id":"2591988670","title":"科华生物（002022）披露产品获得医疗器械注册证，12月16日股价下跌0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591988670","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591988670?lang=zh_cn&edition=full","pubTime":"2025-12-16 17:54","pubTimestamp":1765878896,"startTime":"0","endTime":"0","summary":"截至2025年12月16日收盘，科华生物报收于5.98元，较前一交易日下跌0.66%，最新总市值为30.76亿元。该股当日开盘6.03元，最高6.09元，最低5.93元，成交额达2933.78万元，换手率为0.95%。公司近日发布公告称，其控股子公司西安天隆科技有限公司及全资子公司科华（西安）生物工程有限公司分别收到国家药品监督管理局、陕西省药品监督管理局颁发的医疗器械注册证。上述产品注册证有效期均为五年，将对公司业务发展产生正面影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600030149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","002022","09997","BK0046","BK0028","159883","BK1222","09996","BK0239","BK1100","BK0188","BK1583"],"gpt_icon":0},{"id":"2591622212","title":"北京西城：强化医疗器械监管","url":"https://stock-news.laohu8.com/highlight/detail?id=2591622212","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591622212?lang=zh_cn&edition=full","pubTime":"2025-12-16 06:03","pubTimestamp":1765836180,"startTime":"0","endTime":"0","summary":"（来源：中国消费者报）　　近日，北京市西城区市场监管局开展医疗器械专项检查行动，重点检查医疗器械经营单位是否证照齐全、购进的医疗器械是否保留了相关资质和票据、是否建立验收记录和销售记录、是否存在未及时清理的过期医疗器械等。本报记者董芳忠摄影报道\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-12-16/doc-inhaxvcr1329722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","159883","BK1100","BK1222","BK1574","09996","09997"],"gpt_icon":0},{"id":"2591764210","title":"戴维医疗（300314）披露部分医疗器械产品完成延续注册，12月15日股价上涨1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591764210","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591764210?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:31","pubTimestamp":1765809102,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，戴维医疗报收于12.71元，较前一交易日上涨1.36%，最新总市值为36.6亿元。该股当日开盘12.62元，最高12.81元，最低12.52元，成交额达3243.85万元，换手率为1.78%。本次延续注册完成后，公司可继续生产销售该产品，对公司未来经营具有积极影响，但实际销售情况受市场推广因素影响，目前无法预测其对公司业绩的具体影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500036106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK0046","300314","BK0042","BK0048","BK1100","BK0251","BK1222","BK1574","09996","159883","09997"],"gpt_icon":0},{"id":"2591642983","title":"亚辉龙（688575）披露全资子公司取得医疗器械注册证，12月15日股价下跌2.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591642983","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591642983?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:25","pubTimestamp":1765808757,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，亚辉龙报收于14.1元，较前一交易日下跌2.42%，最新总市值为80.57亿元。公司近日发布公告称，其全资子公司湖南亚辉龙生物科技有限公司取得由湖南省药品监督管理局签发的两项医疗器械注册证，产品为抗磷脂酰丝氨酸/凝血酶原IgM和IgG抗体测定试剂盒，注册分类为二类，有效期至2030年12月11日，预期用途为抗磷脂抗体综合征的辅助诊断。截至目前，公司已取得255个化学发光试剂国内注册证，其中178项为全自动化学发光试剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500035920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","688575","BK0239","09996","BK1222","BK1100","BK1583","BK1574","159883"],"gpt_icon":0},{"id":"2591642362","title":"透景生命（300642）披露控股子公司取得医疗器械注册证，12月15日股价下跌0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591642362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591642362?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:18","pubTimestamp":1765808295,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，透景生命报收于18.4元，较前一交易日下跌0.11%，最新总市值为29.91亿元。该股当日开盘18.31元，最高18.73元，最低18.23元，成交额达5063.15万元，换手率为1.99%。公司近日发布公告称，其控股子公司武汉康录生物技术股份有限公司取得国家药品监督管理局颁发的1项医疗器械注册证，产品名称为产前染色体数目检测试剂盒，注册证编号国械注准20253402555，有效期至2030年12月11日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500035499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1583","BK0239","300642","09997","BK1100","BK1574","BK0042","BK1222","BK0046","09996"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":-0.0115},{"period":"1month","weight":0.153},{"period":"3month","weight":-0.0549},{"period":"6month","weight":-0.0429},{"period":"1year","weight":0.5622},{"period":"ytd","weight":0.5151}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0231},{"period":"3month","weight":-0.0137},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3084},{"period":"ytd","weight":0.2862}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.088172},{"month":2,"riseRate":0.6,"avgChangeRate":0.039503},{"month":3,"riseRate":0.4,"avgChangeRate":-0.110838},{"month":4,"riseRate":0.75,"avgChangeRate":0.044776},{"month":5,"riseRate":0.75,"avgChangeRate":-0.061692},{"month":6,"riseRate":0.666667,"avgChangeRate":0.07739},{"month":7,"riseRate":0.5,"avgChangeRate":0.047595},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.086603},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014494},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005393},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.027135},{"month":12,"riseRate":0.666667,"avgChangeRate":0.084299}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}